| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/09/2006 | US7041484 bound to A-type starch granules in wheat, barley, rye or triticale; not associated with B-type starch granules; starch biosynthesis |
| 05/09/2006 | US7041474 Nucleic acid encoding human tango 509 |
| 05/09/2006 | US7041473 Alzheimer's disease secretase, APP substrates therefor, and uses thereof |
| 05/09/2006 | US7041471 Carotene hydroxylase and method for producing xanthophyll derivatives |
| 05/09/2006 | US7041462 analyzing a non-denatured protein by high pressure liquid chromatography; by using chimeric genes replacing a native signal sequence with a different signal sequence resulting in the production of a conformer, one can compare the native protein with the product of the chimeric gene |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041460 Antibodies to monocyte-colony inhibitory factor (M-CIF) |
| 05/09/2006 | US7041439 Methods and apparatus for selectively processing eggs having identified characteristics |
| 05/09/2006 | US7041438 Conditioned medium collected from a culture of feeder cells with laminin or collagen |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041343 Method for providing a substrate structure for oriented neurite outgrowth, substrate structure, and device for monitoring neuron |
| 05/09/2006 | US7041312 Wound healing compositions and methods of use |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041287 Comprises anticoagulant/thrombolytic agent for selective dissolution of fibrin clots |
| 05/09/2006 | US7041282 Ligands for flt3 receptors |
| 05/09/2006 | CA2417689C Improved methods for growing mammalian cells in vitro |
| 05/09/2006 | CA2156857C Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/09/2006 | CA2093950C Subtilisin-like protease from aspergillus niger |
| 05/05/2006 | CA2523471A1 Expression cassettes for seed-preferential expression in plants |
| 05/04/2006 | WO2006047758A1 Novel technique to fabricate molded structures having a patterned porosity |
| 05/04/2006 | WO2006047743A2 Swine multipotent adult progenitor cells |
| 05/04/2006 | WO2006047639A2 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 05/04/2006 | WO2006047633A2 Radial glial cells promote nerve regeneration and functional recovery following spinal cord injury |
| 05/04/2006 | WO2006047569A2 Methods of expanding myeloid cell populations and uses thereof |
| 05/04/2006 | WO2006047536A2 Methods and kits for detecting mutations |
| 05/04/2006 | WO2006047515A2 Dendritic cells loaded with heat shocked melanoma cell bodies |
| 05/04/2006 | WO2006047426A2 Compositions, methods and systems for preparation of a stem cell-enriched cell population |
| 05/04/2006 | WO2006047412A2 Methods and kits for detecting germ cell genomic instability |
| 05/04/2006 | WO2006047394A1 Therapeutic rnai agents for treating psoriasis |
| 05/04/2006 | WO2006047380A2 Method and media for single cell serum-fee culture of cho cells |
| 05/04/2006 | WO2006047299A2 Organotypic slice cultures and uses thereof |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006046923A1 A method for differentiation of pancreatic stem cells into insulin producing cells |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006046455A1 Novel carbonyl reductase, gene therefor and use thereof |
| 05/04/2006 | WO2006045891A1 Avidin-like proteins from symbiotic bacteria |
| 05/04/2006 | WO2006045438A1 Animal protein-free media for cultivation of cells |
| 05/04/2006 | WO2006045384A1 Model system for testing pharmaceutical preparations with regard to activity in inflammatory processes in the nervous system |
| 05/04/2006 | WO2006045331A1 Differentiation of stem cells and stabilization of phenotypical properties of primary cells |
| 05/04/2006 | WO2006030071A3 Methods for the utilization of novel target genes related to immune-mediated diseases |
| 05/04/2006 | WO2006028723B1 Non-embryonic totipotent blastomer-like stem cells and methods therefor |
| 05/04/2006 | WO2006023148A8 Genetically modified human natural killer cell lines |
| 05/04/2006 | WO2006004728A3 Cell culture medium comprising transition metals or trace elements |
| 05/04/2006 | WO2006002438A3 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 05/04/2006 | WO2005121174A3 Novel g-csf polypeptides, polynucleotides, modulators thereof, and methods of use |
| 05/04/2006 | WO2005118628A3 Nucleic acid molecules encoding plant cyclotide polypeptides and methods of use |
| 05/04/2006 | WO2005117950A3 Regulation of glucose and insulin levels by gnt-4 glycosyltransferase activity |
| 05/04/2006 | WO2005115432A3 Treatment of ocular diseases and disorders using lantibiotic compositions |
| 05/04/2006 | WO2005113750A3 Methods and devices for culturing stem cells |
| 05/04/2006 | WO2005111068A3 A method for purifying and recovering silk proteins using magnetic affinity separation |
| 05/04/2006 | WO2005105981A3 Method and system for reinnervation of muscle |
| 05/04/2006 | WO2005076905A3 Culture media compositions free of fetal bovine serum |
| 05/04/2006 | WO2005071060A3 Methods and devices for microencapsulation of cells |
| 05/04/2006 | WO2003037264A3 Therapeutic anti-hiv (vpr) compounds |
| 05/04/2006 | US20060095992 Wheat plants having increased resistance to imidazolinone herbicides |
| 05/04/2006 | US20060095988 Synthetic plant genes and method for preparation |
| 05/04/2006 | US20060095986 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 05/04/2006 | US20060095981 Transformation of a C3 plant cell with one or more nucleic acids encoding glycolate oxidase, glycolate dehydrogenase, glyoxylate carboligase, or tartronic semialdehyde reductase; trangenic plants, tissues, and cells |
| 05/04/2006 | US20060095979 Transgenic mice containing CLCN4 chloride ion channel gene disruptions |
| 05/04/2006 | US20060095137 Nanofibrous nonwoven membrane of silk fibroin for guided bone tissue regeneration and manufacturing method thereof |
| 05/04/2006 | US20060095089 Method and system for myocardial infarction repair |
| 05/04/2006 | US20060094868 System for cell-based screening |
| 05/04/2006 | US20060094864 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides |
| 05/04/2006 | US20060094863 Nucleic acid capable of hybridizing, serving as a marker for diagnosing feline nephropathy |
| 05/04/2006 | US20060094738 Small molecules that replace or agonize p53 function |
| 05/04/2006 | US20060094675 Method for the repair of mutated RNA from genetically defective DNA and for the specific destruction of tumor cells by RNA trans-splicing, and a method for the detection of naturally trans-spliced cellular RNA |
| 05/04/2006 | US20060094647 Treatment of inflammatory bowel disease using growth factors |
| 05/04/2006 | US20060094116 High-efficiency wild-type-free AAV helper functions |
| 05/04/2006 | US20060094115 Method for the production of cells with increased development potential |
| 05/04/2006 | US20060094114 Animal product-free cell culture medial extracts, supplements and culture media supplement systems |
| 05/04/2006 | US20060094113 Chemically defined media compositions |
| 05/04/2006 | US20060094112 Biological scaffold |
| 05/04/2006 | US20060094111 DNA containing variant FRT sequences |
| 05/04/2006 | US20060094104 Nutrient broth comprising polyamines and plant and/or yeast-derived hydrolysate for propagation of transgenic/infected cells |
| 05/04/2006 | US20060094079 Protein for blocking platelet adhesion |
| 05/04/2006 | US20060094050 High fidelity reverse transcriptases and uses thereof |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060094031 Alpha-L-arabinofuranosidase histochemical reporter gene assay |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | US20060093606 Compositions and methods of using angiopoietin-like 4 protein |
| 05/04/2006 | US20060093605 Expansion of NK cells and therapeutic uses thereof |
| 05/04/2006 | US20060093604 Method of treatment and prophylaxis |
| 05/04/2006 | US20060093600 Antibodies to CD40 |
| 05/04/2006 | US20060093590 Pseudotyped retroviruses |
| 05/04/2006 | US20060093587 Transplants for myocardial scars |
| 05/04/2006 | US20060093586 Generation and differentiation of adult stem cell lines |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/04/2006 | US20060093581 Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both: methods for obtaining same; and their uses |
| 05/04/2006 | US20060093575 Oxaliplatin anti-resistance agent |
| 05/04/2006 | DE10260431B4 Verfahren zur selbstjustierenden Immobilisierung lebender Zellen auf einem Substrat auf Silizium-Basis A process for self-aligning the immobilization of living cells on a substrate based on silicon |
| 05/04/2006 | DE102004053164A1 Coated microcarrier, useful for culturing animal, human or microbial cells, comprises particulate inorganic matrix coated with an epoxide-amine polymer |
| 05/04/2006 | CA2585970A1 Mammalian genes involved in infection |
| 05/04/2006 | CA2585518A1 Animal protein-free media for cultivation of cells |
| 05/04/2006 | CA2585343A1 Methods of expanding myeloid cell populations and uses thereof |
| 05/04/2006 | CA2585156A1 Duffy antigen receptor for chemokines and use thereof |
| 05/04/2006 | CA2583826A1 Therapeutic rnai agents for treating psoriasis |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/04/2006 | CA2582550A1 Rna constructs |